211859-58-4

Basic information

• Product Name: 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxatriacontane
• Synonyms: 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxatriacontane
• CAS NO: 211859-58-4
• Molecular Weight: 518.645
• Mol File: 211859-58-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxatriacontane(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxatriacontane(211859-58-4)
• EPA Substance Registry System: 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxatriacontane(211859-58-4)

Safety Data

• Hazardous Substances Data: 211859-58-4(Hazardous Substances Data)

Upstream product

• 23601-40-3 hexaethylene glycol monomethyl ether 
• 84131-04-4 triethylene glycol monobenzyl tosyl ether 
• 24342-68-5 1-phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol 
• 62921-74-8 2-(2-(2-methoxyethoxy)ethoxy)ethyl p-toluenesulfonate 

Downstream Products

• 6048-68-6 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-ol 

Relevant articles and documents

PROCESS FOR PREPARING NONAETHYLENE GLYCOL MONOMETHYL ETHER

The present invention provides a process for preparing nonethylene glycol monomethyl ether.

Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders

The present invention provides a compound of formula (I) or a solvate thereof wherein: X is —O— or —NH—; Q is (—CH2—)p, (—CH═CH—)p, (—C≡C—)pwhere p is an integer of from 0 to 4; R1is hydrogen or methyl; R2and R3independently represent O or S n is an integer of 1 to 50; and R is hydrogen or methyl. The present invention also provides pharmaceutical compositions and methods of treatment using the compounds of formula (I). The compounds of the present invention are useful for the prophylaxis and treatment of septic shock, inflammatory conditions and immune disorders.